PP
VRTX icon

Pingora Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Pingora Partners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29K Hold
65
– – 0.02% 159
2025
Q4 		$29.5K Hold
65
– – 0.02% 152
2025
Q3 		$25.5K Hold
65
– – 0.02% 155
2025
Q2 		$28.9K Hold
65
– – 0.02% 151
2025
Q1 		$31.5K Hold
65
– – 0.02% 144
2024
Q4 		$26.2K Hold
65
– – 0.02% 165
2024
Q3 		$30.2K Sell
65
-8
-11% -$3.84K 0.02% 161
2024
Q2 		$34.2K Hold
73
– – 0.02% 156
2024
Q1 		$30.5K Buy
+73
New +$30.9K 0.02% 171

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pingora Partners's VRTX Position: Q1 2026 in Review

Pingora Partners held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 65 shares worth $29K. The position accounts for 0.02% of the portfolio, ranked #159.

Pingora Partners first reported a position in VRTX in Q1 2024 and has held it in 9 quarters since. The position peaked at $34.2K in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Pingora Partners held 65 shares of Vertex Pharmaceuticals worth $29K as of Q1 2026.
  • Pingora Partners left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up 0.02% of Pingora Partners's portfolio in Q1 2026, its #159 holding.
  • Pingora Partners first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Pingora Partners's Vertex Pharmaceuticals position peaked at $34.2K in Q2 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Pingora Partners's 13F filing for Q1 2026, filed 15 May 2026.